跳至主要内容
临床试验/NCT00781599
NCT00781599已完成不适用

Improving Medication Compliance and Smoking Cessation Treatment Outcomes for African American Smokers

Nikki Nollen, PhD, MA1 个研究点 分布在 1 个国家目标入组 72 人开始时间: 2008年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
72
试验地点
1
主要终点
Percent Compliance With Chantix

研究概览

简要总结

Little is known about the support needed to improve compliance with Chantix for smoking cessation. This is a two arm pilot study of African American smokers to provide varying levels of side effect management and compliance support during a 12 week treatment period. The primary aim of the study is to estimate the effect of induction support compared to standard care in increasing compliance with Chantix at month 3

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • African American
  • 18-75 years of age
  • Smoke more than 10 cigarettes per day
  • Have a functioning telephone number
  • Be interested in quitting smoking
  • Be willing to take 3 months of Chantix
  • Be willing to complete all study visits

排除标准

  • Renal impairment
  • Evidence or history of clinically significant allergic reactions to Chantix
  • Cardiovascular event in the past month
  • History of alcohol or drug abuse/dependency in the past year
  • Major depressive disorder in the last year requiring treatment
  • History of panic disorder
  • Psychosis, bipolar or eating disorder
  • Use of antidepressants, antipsychotics, mood stabilizers/anticonvulsants or naltrexone
  • Use of tobacco products other than cigarettes
  • Use of nicotine replacement therapy, bupropion, clonidine or nortriptyline in the month prior to enrollment
  • Prior use of Chantix
  • Women who are pregnant, contemplating getting pregnant or breastfeeding
  • Plans to move from Kansas City during the 3 month treatment phase
  • Another household member enrolled in the study

研究组 & 干预措施

1

Active Comparator

Chantix for 3 months and Standard Counseling

干预措施: Chantix (Drug)

1

Active Comparator

Chantix for 3 months and Standard Counseling

干预措施: Standard Counseling (Behavioral)

2

Experimental

Chantix for 3 months and Adherence Counseling

干预措施: Chantix (Drug)

2

Experimental

Chantix for 3 months and Adherence Counseling

干预措施: Adherence Counseling (Behavioral)

2

Experimental

Chantix for 3 months and Adherence Counseling

干预措施: Standard Counseling (Behavioral)

结局指标

主要结局

Percent Compliance With Chantix

时间窗: Months 1, 2, 3

Compliance with Chantix calculated as the total doses taken over the total number of doses prescribed. Adherence was measured by pill counts. Measurements taken during monthly medication refill visits. There was no specific predetermined cutoff number on the scale which determined non-compliance. All results from compliance calculations are included in the table.

次要结局

  • Cotinine Verified 7 Day Point Prevalence Smoking Abstinence(Month 3)
  • Carbon Monoxide-verified Abstinence(Month 2)

研究者

发起方
Nikki Nollen, PhD, MA
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Nikki Nollen, PhD, MA

Assistant Professor

University of Kansas Medical Center

研究点 (1)

Loading locations...

相似试验